MHRA adds Allevia (fexofenadine hydrochloride) 120mg tablets to General Sales List.

Allevia is used for relief of symptoms associated with seasonal allergic rhinitis (SAR), or hayfever, in adults and children aged ≥12 years. It will remain a POM as 180mg tablets for chronic idiopathic urticaria and 30mg tablets for SAR symptoms in children aged 6–11 years.

Source:

Pharmaceutical Journal